Leptin, hs-CRP and HOMA-IR in patients with type 2 diabetes: The role of different levels of vitamin D deficiency

Authors

  • Salome Sadat Salehi‍ Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Soghra Rabizadeh Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Sahar Karimpour Reyhan Reyhan Karimpour Internal Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  • Marjan Mouodi Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Manouchehr Nakhjavani Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Alireza Esteghamati Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
  • Hossein Mirmiranpour Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.31989/ffhd.v9i11.661

Abstract

Background: To evaluate the effects of different levels of vitamin D deficiency on blood glucose, leptin, high sensitivity C-reactive protein (hs-CRP), and insulin resistance and their associations. 

Methods: We quantified serum vitamin D level, hs-CRP, leptin, and fasting  blood  sugar (FBS)  levels in 25 type-2 diabetic patients with deficient serum levels of 25-hydroxy vitamin D (≤15 ng/ml) and 25 type-2 diabetic patients with insufficient serum levels of 25-hydroxy vitamin D (16 to 30 ng/ml). The two groups were matched according to age, sex, and body mass index (BMI). Homeostasis model assessment of insulin resistance (HOMA-IR) was  calculated  by  a  formula based  upon  values  of  FBS and insulin concentrations.

Results: The mean value of vitamin D levels was 7.67±3.10 in the vitamin D deficient group and 23.20±9.97 in the vitamin D insufficient group. Patients with vitamin D deficiency had significantly higher FBS, postprandial glucose (PPG) and hemoglobin A1C (HbA1C) as compared to vitamin D insufficient group (p<0.01). We studied correlations of hs-CRP, HOMA-IR, and leptin in both vitamin D insufficient and deficient groups. There were significant positive correlations between leptin with hs-CRP (r = 0.58, p<0.01) and with HOMA-IR (r = 0.49, p<0.05) in vitamin D deficient group. These correlations remained significant after multiple adjustments for age, sex, BMI, systolic and diastolic blood pressure.                                                                                                                        

Conclusion: In conclusion, vitamin D deficient diabetic patients had elevated FBS, PPG and HbA1C compared with insufficient ones. The results also could possibly point the effect of vitamin D deficiency level on leptin associations with hs-CRP and insulin resistance.

Keywords: Vitamin D deficiency, type 2 diabetes, leptin, C reactive protein, homeostasis model assessment of insulin resistance  

Downloads

Published

2019-11-30

Issue

Vol. 9 No. 11 (2019): November 2019

Section

Research Articles

License

Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request. 

 

Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.